Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
DepYmed to Meet with Investors at the 34th Annual Oppenheimer Healthcare Life Sciences Conference | ||
By: GlobeNewswire - 07 Feb 2024 | Back to overview list |
|
FARMINGDALE, N.Y., Feb. 07, 2024 (GLOBE NEWSWIRE) -- DepYmed, Inc. (“DepYmed” or the “Company”) is a preclinical stage pharmaceutical company focused on developing transformative treatments for rare diseases and oncology that target the protein tyrosine phosphatase (PTP) family of enzymes. Today the Company announces that management will be meeting with investors at the 34th Annual Oppenheimer Healthcare Life Sciences Conference held virtually on February 13-14, 2024. Interested qualified investors must register for the conference through Oppenheimer’s customer portal, and may arrange meetings either through the conference portal or directly with the Company via email at info@depymedinc.com. Investors are requested to preregister for the event. About the 34th Annual Oppenheimer Healthcare Life Sciences Conference About DepYmed, Inc. For Media Inquiries please contact: Jules Abraham DepYmed:
|
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |